FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17814411000001100: Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61381801000001110 Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
61381901000001116 Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Is a Cabergoline 2mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Has AMP Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Phoenix Healthcare Distribution Ltd) 20 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start